Getting to the future first
Reimagining Healthcare to transform lives
Our aim is to be globally admired for reimagining healthcare and transforming one billion lives
Founded in 2017 and headquartered in London, RYSE is a leading venture capital firm driving the future of healthcare through HealthTech innovation.
RYSE backs innovators who bridge gaps in access, quality, and delivery, sourcing transformative technologies in underserved areas to drive both impact and commercial returns. Our focus is on addressing unmet clinical needs, improving access, and making healthcare more affordable.
Through collaborations with industry leaders like DigitalHealth.London, the NHS, Novartis, and Medtronic, RYSE bridges the gap between visionary ideas and real-world impact. RYSE specialises in empowering bold founders globally at the early stages, typically investing in Seed and Series A HealthTech companies.
Meet our team
RYSE is led by a diverse and experienced team driven by a shared mission to build innovation in healthcare. RYSE creates value by supporting early-stage companies to scale their revenue and distribution. The team works with exceptional founders to negotiate attractive contracts with our established distribution partners.
Our focus is to help founders go further
RYSE backs visionary founders who are driving transformative change in HealthTech, tackling global healthcare challenges such as an ageing population, the rise of chronic diseases, and the demand for more efficient care delivery.
Our focus on tech-enabled health solutions — across digital diagnostics, digital therapeutics, medical devices and data and discovery platforms — all designed to make healthcare more affordable, accessible, and impactful. With deep expertise in cardiovascular health, metabolic disorders, oncology, mental health, women’s health, and health AI, RYSE is committed to empowering innovations that redefine the future of healthcare.
Partnerships
Our partners work with us to translate new science and technology into real-world solutions
Latest News
RYSE Asset Management: Invests in Curio Digital Therapeutics to support the development of new therapeutics for underserved women’s mental health conditions
